Ignite Creation Date:
2025-12-26 @ 10:17 PM
Ignite Modification Date:
2026-05-05 @ 7:09 AM
Study NCT ID:
NCT05293912
Status:
TERMINATED
Last Update Posted:
2025-03-18
First Post:
2022-03-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
SG2501 Safety Study in Subjects with Relapsed or Refractory Hematological Malignancies and Lymphoma.
Sponsor:
Hangzhou Sumgen Biotech Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CSG-2501-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None